Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BEVESPI AEROSPHERE | AstraZeneca | N-208294 RX | 2016-04-25 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BREZTRI AEROSPHERE | AstraZeneca | N-212122 RX | 2020-07-23 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SYMBICORT | AstraZeneca | N-021929 RX | 2006-07-21 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SYMBICORT AEROSPHERE | AstraZeneca | N-216579 RX | 2023-04-28 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DUAKLIR PRESSAIR | Covis Pharma | N-210595 RX | 2019-03-29 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
bevespi aerosphere | New Drug Application | 2023-03-24 |
bretzri | New Drug Application | 2020-07-23 |
breyna | ANDA | 2020-09-24 |
breztri | New Drug Application | 2022-01-26 |
budesonide and formoterol fumarate dihydrate | NDA authorized generic | 2024-10-22 |
duaklir pressair | New Drug Application | 2022-08-01 |
dulera | New Drug Application | 2025-02-10 |
foradil | New Drug Application | 2012-03-01 |
formoterol fumarate | ANDA | 2025-04-18 |
formoterol fumarate inhalation solution | ANDA | 2025-03-07 |
Expiration | Code | ||
---|---|---|---|
BUDESONIDE / FORMOTEROL FUMARATE / GLYCOPYRROLATE, BREZTRI AEROSPHERE, ASTRAZENECA AB | |||
2023-07-23 | NC | ||
FORMOTEROL FUMARATE / MOMETASONE FUROATE, DULERA, ORGANON LLC | |||
2023-02-12 | PED |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Budesonide / Formoterol Fumarate / Glycopyrrolate, Breztri Aerosphere, Astrazeneca Ab | |||
11331442 | 2038-10-05 | DP | |
11833292 | 2038-10-05 | DP | |
8815258 | 2031-03-17 | U-2889 | |
8324266 | 2030-05-28 | U-2889 | |
8703806 | 2030-05-28 | U-2889 | |
8808713 | 2030-05-28 | DP | U-2889 |
9463161 | 2030-05-28 | DP | U-2889 |
Budesonide / Formoterol Fumarate, Symbicort Aerosphere, Astrazeneca | |||
9415009 | 2030-05-28 | U-2889, U-3203 | |
10716753 | 2030-05-28 | DP | U-2889, U-3203 |
Aclidinium Bromide / Formoterol Fumarate, Duaklir Pressair, Covis | |||
10085974 | 2029-03-13 | DP | U-2513 |
11000517 | 2029-03-13 | DP | U-2513 |
8051851 | 2027-04-22 | DP | |
RE46417 | 2025-02-10 | DS, DP | U-2513 |
Code | Description |
---|---|
J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
J7640 | Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Asthma | D001249 | EFO_0000270 | J45 | — | — | 1 | — | — | 1 |
Aspergillosis | D001228 | EFO_0007157 | B44 | — | 1 | 1 | — | — | 1 |
Allergic bronchopulmonary aspergillosis | D001229 | EFO_0007140 | B44.81 | — | 1 | 1 | — | — | 1 |
Pulmonary aspergillosis | D055732 | EFO_1001834 | — | — | 1 | 1 | — | — | 1 |
Drug common name | Formoterol |
INN | formoterol |
Description | N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide is a phenylethanoloamine having 4-hydroxy and 3-formamido substituents on the phenyl ring and an N-(4-methoxyphenyl)propan-2-yl substituent. It is a member of phenols, a member of formamides, a secondary amino compound, a secondary alcohol and a member of phenylethanolamines. |
Classification | Small molecule |
Drug class | bronchodilators (phenethylamine derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1 |
PDB | — |
CAS-ID | 73573-87-2 |
RxCUI | — |
ChEMBL ID | CHEMBL1256786 |
ChEBI ID | 63082 |
PubChem CID | 3410 |
DrugBank | DB00983 |
UNII ID | 5ZZ84GCW8B (ChemIDplus, GSRS) |